medical_comorbidities | CARLAT PUBLISHING

CLINICAL UPDATE

Six Tips for Working With Older Adults

March 26, 2021

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Rehan Aziz, MD, explains how to interview older adults and which medications to use and which ones to avoid in this population.

RESEARCH UPDATE

Beta Blockers and Depression: The Controversy Revisited

December 31, 2020

Sean Ransom, Ph.D

Sean Ransom, Ph.D Dr. Ransom has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There is an age-old debate about whether blood pressure medications cause depression. This study is one of the largest to tackle the issue, and it suggests this risk may be limited to one class of antihypertensives in particular.

RESEARCH UPDATE

Beta Blockers and Depression: The Controversy Revisited

November 12, 2020

Sean Ransom, PhD, MP.

Sean Ransom, PhD, MP. Dr. Ransom has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antihypertensives are among the world’s most widely prescribed drugs, but many of them impact pathways associated with depression. Beta blockers have long been believed to cause depression, but most of these studies were carried out decades ago and their findings have been inconsistent.

How COVID-19 Affects the Brain

September 3, 2020

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Pandemics create a long list of psychosocial stressors, but COVID-19 also has direct effects on the CNS. Neuropsychiatric syndromes can develop after the respiratory illness resolves. Paul Riordan reviews the cardinal symptoms to look for after a COVID infection.

EXPERT Q&A

Inflammatory Biomarkers in Depression

February 10, 2020

Andrew H. Miller, MD

Andrew H. Miller, MD

William P. Timmie Professor of Psychiatry and Behavioral Sciences, Emory University, GA Dr. Miller has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Andrew Miller, Vice Chair of Psychiatry Research at Emory University, translates two decades research on inflammation and depression into practical terms, including a low-cost biomarker that may guide antidepressant selection.

CLINICAL UPDATE

Primer: Physical Examination in Addiction Practice

November 22, 2019

Whether you are referring your patient for a physical or doing an initial one yourself, clinicians should be familiar with the basics of physical examination with a focus on knowing how to look for medical complications of addiction. This article walks you through a basic physical exam and what signs and symptoms to look for in patients with current or past substance use.

Screening and Prophylaxis of Infectious Diseases in Addiction Practice

November 22, 2019

Sandra Springer, MD

Sandra Springer, MD

Associate Professor of Medicine in the Department of Internal Medicine, Yale School of Medicine. Director of the Infectious Disease Clinic (Newington) and Attending Infectious Disease Physician (West Haven), VA Connecticut Healthcare System.

Dr. Springer has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this QA, we invite Dr. Sandra Springer to walk us through the various screenings for infectious diseases ranging from HIV to Hepatitis A, Hepatitis B, and Hepatitis C, as well as Tuberculosis.

PrEP: Introduction to the Basics

November 22, 2019

With the rate of new HIV infections at just under 40,000 new infections per year, it is important for addiction practitioners to be on the front lines of HIV prevention. This article and corresponding table cover the pre-exposure prophylaxis (PrEP) with Truvada.

Perioperative Management of Patients on Buprenorphine Maintenance

November 22, 2019

Gregory Acampora, MD

Gregory Acampora, MD

Psychiatrist, Pain Management Center, Massachusetts General Hospital/Harvard Center for Addiction Medicine, Boston, MA. Assistant Professor, Harvard Medical School.

Dr. Acampora has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

For patients on buprenorphine maintenance facing surgery, it is crucial to balance the need to minimize pain while addressing the risk of relapse. In this interview, Dr. Gregory Acampora guides us through the specifics on perioperatively managing patients on varying doses of buprenorphine maintenance.

Mood Stabilizers and Stroke Risk in Bipolar Disorder

July 3, 2019

Thomas Jordan, MD.

Thomas Jordan, MD. Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity

Why does stroke matter in bipolar disorder? Because it’s the leading cause of death for these patients. Some mood stabilizers raise the stroke risk, while others do not.